Copyright
©The Author(s) 2024.
World J Virol. Jun 25, 2024; 13(2): 90668
Published online Jun 25, 2024. doi: 10.5501/wjv.v13.i2.90668
Published online Jun 25, 2024. doi: 10.5501/wjv.v13.i2.90668
Table 3 Electrocardiogram changes after treatment (day 14 of randomization)
| Variable | Days 14-1 | Day 1 | Day 14 | P value |
| Heart rate (/min) | 0.820 | 78 ± 13 | 79 ± 12 | 0.343 |
| P wave (ms) | 1.010 | 114 ± 10 | 115 ± 13 | 0.314 |
| PR space (ms) | 8.232 | 170 ± 28 | 177 ± 36 | 0.001 |
| QRS complex (ms) | 0.469 | 76 ± 13 | 76 ± 13 | 0.560 |
| QTc interval (ms) | 8.835 | 405 ± 30 | 413 ± 35 | < 0.001 |
| T-wave (ms) | 3.867 | 193 ± 32 | 197 ± 42 | 0.197 |
| Sokolow–Lyon (mm) | 0.004 | 24.5 ± 8.9 | 24.5 ± 8.5 | 0.990 |
- Citation: Madioko Makanzu B, Makulo JR, Ndona Mandina M, Wumba DR, Mashi Longokolo M, Situakibanza H, Odio O, Sonzi Mangala D, Mihigo Bashengezi C, Kabwe Mwilambwe B, Kabanda Kurhenga G, Longo-Mbenza B, Mwimba Mbungu R. Hydroxychloroquine-azithromycin, doubase C, and QTc prolongation in congolese patients with COVID-19: Myth or reality? World J Virol 2024; 13(2): 90668
- URL: https://www.wjgnet.com/2220-3249/full/v13/i2/90668.htm
- DOI: https://dx.doi.org/10.5501/wjv.v13.i2.90668